BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study | Zendy

David B. Zhen | Zendy; Kari G. Rabe | Zendy; Steven Gallinger | Zendy; Sapna Syngal | Zendy; Ann G. Schwartz | Zendy; Michael Goggins | Zendy; Ralph H. Hruban | Zendy; Michele L. Coté | Zendy; Robert R. McWilliams | Zendy; Nicholas J. Roberts | Zendy; Lisa CanAlbright | Zendy; Donghui Li | Zendy; Kelsey Moyes | Zendy; Richard Wenstrup | Zendy; Anne-Renee Hartman | Zendy; Daniela Seminara | Zendy; Alison P. Klein | Zendy; Gloria M. Petersen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study

Author(s) -

David B. Zhen,

Kari G. Rabe,

Steven Gallinger,

Sapna Syngal,

Ann G. Schwartz,

Michael Goggins,

Ralph H. Hruban,

Michele L. Coté,

Robert R. McWilliams,

Nicholas J. Roberts,

Lisa CanAlbright,

Donghui Li,

Kelsey Moyes,

Richard Wenstrup,

Anne-Renee Hartman,

Daniela Seminara,

Alison P. Klein,

Gloria M. Petersen

Publication year - 2014

Publication title -

genetics in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.509

H-Index - 128

eISSN - 1530-0366

pISSN - 1098-3600

DOI - 10.1038/gim.2014.153

Subject(s) - cdkn2a , palb2 , pancreatic cancer , proband , family history , medicine , germline mutation , chek2 , cancer , oncology , genetic testing , genetics , mutation , biology , gene

Familial pancreatic cancer kindreds contain at least two affected first-degree relatives. Comprehensive data are needed to assist clinical risk assessment and genetic testing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research